160 related articles for article (PubMed ID: 10908013)
21. An tale of two epidemics: HIV and stimulant use.
Gorman M
Focus; 1998 Mar; 13(4):1-3. PubMed ID: 11365170
[TBL] [Abstract][Full Text] [Related]
22. Repeated psychological stress testing in stimulant-dependent patients.
Harris DS; Reus VI; Wolkowitz OM; Mendelson JE; Jones RT
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):669-77. PubMed ID: 15913869
[TBL] [Abstract][Full Text] [Related]
23. [Patterns of cocaine use among cocaine users who do not use heroin recruited outside of treatment centers].
Barrio-Anta G; López-Gigosos R; de la Fuente de Hoz L; Rodríguez-Artalejo F
Med Clin (Barc); 1997 Sep; 109(10):364-9. PubMed ID: 9379717
[TBL] [Abstract][Full Text] [Related]
24. Drug use patterns and drug-related disorders of cocaine users in a sample of the general population in Germany.
Kraus L; Augustin R; Kunz-Ebrecht S; Orth B
Eur Addict Res; 2007; 13(2):116-25. PubMed ID: 17356284
[TBL] [Abstract][Full Text] [Related]
25. Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25.
Herman-Stahl MA; Krebs CP; Kroutil LA; Heller DC
Addict Behav; 2007 May; 32(5):1003-15. PubMed ID: 16920275
[TBL] [Abstract][Full Text] [Related]
26. Treatment response by primary drug of abuse: does methamphetamine make a difference?
Luchansky B; Krupski A; Stark K
J Subst Abuse Treat; 2007 Jan; 32(1):89-96. PubMed ID: 17175402
[TBL] [Abstract][Full Text] [Related]
27. Risk and protective factors for nonmedical use of prescription stimulants and methamphetamine among adolescents.
Herman-Stahl MA; Krebs CP; Kroutil LA; Heller DC
J Adolesc Health; 2006 Sep; 39(3):374-80. PubMed ID: 16919799
[TBL] [Abstract][Full Text] [Related]
28. Determinants of seeking treatment for cocaine abuse: a case-control study.
Pavarin RM; Consonni D; Berardi D
Eur Addict Res; 2013; 19(2):61-7. PubMed ID: 23006508
[TBL] [Abstract][Full Text] [Related]
29. Cocaine and methamphetamine abuse are primary focus of new guidelines for treating stimulant use disorders.
Psychiatr Serv; 1999 Aug; 50(8):1099-100. PubMed ID: 10445666
[No Abstract] [Full Text] [Related]
30. Differences between Ecstasy-using and nonusing methamphetamine users.
Brecht ML; von Mayrhauser C
J Psychoactive Drugs; 2002; 34(2):215-23. PubMed ID: 12691212
[TBL] [Abstract][Full Text] [Related]
31. Combinations of oxazepam and metyrapone attenuate cocaine and methamphetamine cue reactivity.
Keller CM; Cornett EM; Guerin GF; Goeders NE
Drug Alcohol Depend; 2013 Dec; 133(2):405-12. PubMed ID: 23896309
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology and public health Consequences of methamphetamine use in California's Central Valley.
Gibson DR; Leamon MH; Flynn N
J Psychoactive Drugs; 2002; 34(3):313-9. PubMed ID: 12422943
[TBL] [Abstract][Full Text] [Related]
33. A descriptive analysis of participant characteristics and patterns of substance use in the CSAT methamphetamine treatment project: the first six months.
Reiber C; Galloway G; Cohen J; Hsu JC; Lord RH
J Psychoactive Drugs; 2000; 32(2):183-91. PubMed ID: 10908006
[TBL] [Abstract][Full Text] [Related]
34. Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment.
Shoptaw S; Peck J; Reback CJ; Rotheram-Fuller E
J Psychoactive Drugs; 2003 May; 35 Suppl 1():161-8. PubMed ID: 12825759
[TBL] [Abstract][Full Text] [Related]
35. Essential/precursor chemicals and drug consumption: impacts of US sodium permanganate and Mexico pseudoephedrine controls on the numbers of US cocaine and methamphetamine users.
Cunningham JK; Liu LM; Callaghan RC
Addiction; 2016 Nov; 111(11):1999-2009. PubMed ID: 27529812
[TBL] [Abstract][Full Text] [Related]
36. All-cause mortality among individuals with disorders related to the use of methamphetamine: a comparative cohort study.
Callaghan RC; Cunningham JK; Verdichevski M; Sykes J; Jaffer SR; Kish SJ
Drug Alcohol Depend; 2012 Oct; 125(3):290-4. PubMed ID: 22503689
[TBL] [Abstract][Full Text] [Related]
37. [Emotion regulation among psychostimulants drug users at techno parties].
Lillaz C; Varescon I
Encephale; 2012 Oct; 38(5):390-6. PubMed ID: 23062452
[TBL] [Abstract][Full Text] [Related]
38. Methamphetamine use and dental disease: results of a pilot study.
Cretzmeyer M; Walker J; Hall JA; Arndt S
J Dent Child (Chic); 2007; 74(2):85-92. PubMed ID: 18477425
[TBL] [Abstract][Full Text] [Related]
39. A comparison of injecting and noninjecting methamphetamine users.
Domier CP; Simon SL; Rawson RA; Huber A; Ling W
J Psychoactive Drugs; 2000; 32(2):229-32. PubMed ID: 10908012
[TBL] [Abstract][Full Text] [Related]
40. Methamphetamine abuse: a perfect storm of complications.
Lineberry TW; Bostwick JM
Mayo Clin Proc; 2006 Jan; 81(1):77-84. PubMed ID: 16438482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
